Dr. Harald Hübner

Lehrstuhl für Pharmazeutische Chemie

Structure-Based Evolution of G Protein-Biased μ-Opioid Receptor Agonists (2022) Wang H, Hetzer F, Huang W, Qu Q, Meyerowitz J, Kaindl J, Hübner H, et al. Journal article Functionally selective activation of the dopamine receptor D2 is mirrored by the protein expression profiles (2021) Wenk D, Ignatchenko V, Macklin A, Hübner H, Gmeiner P, Weikert D, Pischetsrieder M, Kislinger T Journal article Optimizing the expression of human dopamine receptors in escherichia coli (2021) Boritzki V, Hübner H, Allikalt A, Gmeiner P, Wöhrl BM Journal article Abolishing Dopamine D2long/D3Receptor Affinity of Subtype-Selective Carbamoylguanidine-Type Histamine H2Receptor Agonists (2021) Tropmann K, Bresinsky M, Forster L, Mönnich D, Buschauer A, Wittmann HJ, Hübner H, et al. Journal article Radiosynthesis and evaluation of F-18-labeled dopamine D-4-receptor ligands (2021) Willmann M, Ermert J, Prante O, Hübner H, Gmeiner P, Neumaier B Journal article Homobivalent Dopamine D2Receptor Ligands Modulate the Dynamic Equilibrium of D2Monomers and Homo-and Heterodimers (2021) Ullmann T, Gienger M, Budzinski J, Hellmann J, Hübner H, Gmeiner P, Weikert D Journal article Presynaptic vesicular accumulation is required for antipsychotic efficacy in psychotic-like rats (2021) Uzuneser T, Weiss EM, Dahlmanns J, Kalinichenko L, Amato D, Kornhuber J, Alzheimer C, et al. Journal article, Original article Binding pathway determines norepinephrine selectivity for the human β1AR over β2AR (2021) Xu X, Kaindl J, Clark MJ, Hübner H, Hirata K, Sunahara RK, Gmeiner P, et al. Journal article, Original article Fluorescent ligands for dopamine D-2/D-3 receptors (2020) Allikalt A, Purkayastha N, Flad K, Schmidt M, Tabor A, Gmeiner P, Hübner H, Weikert D Journal article, Original article Structure-based development of caged dopamine D2/D3 receptor antagonists (2020) Gienger M, Hübner H, Löber S, König B, Gmeiner P Journal article